A fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066.
De Fusco, C., Brear, P., Iegre, J., Georgiou, K.H., Sore, H.F., Hyvonen, M., Spring, D.R.(2017) Bioorg Med Chem 25: 3471-3482
- PubMed: 28495381 
- DOI: 10.1016/j.bmc.2017.04.037
- Primary Citation of Related Structures:  
5MMR, 5MMF, 5MO6, 5MO5, 5MOT, 5MOV, 5MOH, 5MOD, 5MOE, 5MO8 - PubMed Abstract: 
Recently we reported the discovery of a potent and selective CK2α inhibitor CAM4066. This compound inhibits CK2 activity by exploiting a pocket located outside the ATP binding site (αD pocket). Here we describe in detail the journey that led to the disco ...